Potential Corporate Restructuring
According to the Financial Times report, the discussions regarding a potential split are at an early stage and no final decision has been made. Under the plans being considered, CVS could spin off its retail pharmacy business into a separately listed company.
If this restructuring proceeds, the report added that Aetna and the pharmacy benefit manager Caremark would remain together under one corporate entity. This move would represent a significant reversal of CVS' strategy of building an integrated healthcare business through acquisitions. One such acquisition included its roughly $78 billion purchase of health insurer Aetna in 2018.
CVS Health did not immediately respond to a Reuters request for comment regarding the report.